Antibe Therapeutics Inc. Reports Q3 2015 Interim Financial And Operating Results And Director Resignation
TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (“Antibe”) (TSXV:ATE, OTCQX:ATBPF) filed its financial and operating results today for the fiscal quarter ended December 31, 2014. The Corporation’s unaudited Q3 2015 financial statements and MD&A are available on SEDAR.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.